Adenosquamous cell lung cancer stage 0

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Owlstone Medical Limited Commercial
    D5-ETHYL-BETA-D-GLUCURONIDE
    2023-503574-20-00 2 countries 2023 n=100
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Owlstone Medical Limited Commercial 1 Phase II 0
New trials by year
2023
1
← All indication landscapes